General Hospital of Thessaloniki Ahepa
Thessaloniki 54636
0 studies enrolling now · 4 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Coronary Heart Disease (CHD), Type 2 Diabetes Mellitus (T2DM)
Studies at this site
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed